NEPHROSTERIL INFUSION contains Amino acid which are naturally occurring physiological compounds. It is used for management of protein depletion in patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or not recommended. NEPHROSTERIL INFUSION can be used to manage negative nitrogen balance in patients. NEPHROSTERIL INFUSION can also be used to manage hepatic encephalopathy in patients with liver scarring or inflammation. Your doctor might monitor your fluid an electrolyte status and various other functions throughout your management. NEPHROSTERIL INFUSION is not recommended for use in patients with amino acid metabolism problems since birth, pulmonary edema, or excess acid in blood due to low cardiac output. Before receiving NEPHROSTERIL INFUSION, inform your doctor if you have diabetes, kidney, heart, or liver disease. NEPHROSTERIL INFUSION should be used in pregnant and breastfeeding women only if considered clearly necessary. NEPHROSTERIL INFUSION is not recommended for use in children and should be used with caution in elderly patients, therefore consult your doctor before receiving it. The most common side effects of receiving NEPHROSTERIL INFUSION are generalized flushing, fever, nausea, and local injection site reactions. Contact your doctor if any of the symptoms worsen.

FLURACIL 250MG INJECTION contains Fluorouracil, which belongs to a group of medicines called Nucleoside metabolic inhibitors. FLURACIL 250MG INJECTION is used to manage cancer involving the breast, oesophagus, stomach, colon, rectum, pancreas, prostate, ovary, bladder, and head and neck cancer. FLURACIL 250MG INJECTION should not be used in patients with serious infections (for example, Herpes zoster or chickenpox), non-malignant tumours, poor nutrition, weakened immunity due to long illness, damaged bone marrow due to other antineoplastics or radiotherapy, severe liver disease, or homozygotic or complete deficiency of dihydropyrimidine dehydrogenase (DPD) enzyme. FLURACIL 250MG INJECTION should be used with caution in patients with decreased blood cells, oral ulcers, fever or haemorrhage at any site or weakness (due to decreased blood cells), kidney or liver problems like jaundice (yellowing of the skin) or heart problems like chest pain, reduced activity or deficiency of the enzyme DPD (dihydropyrimidine dehydrogenase), had high-dose radiation to pelvic, spine, ribs, metastatic tumours with involvement of bone marrow, severe bone marrow suppression include neutropenia, thrombocytopenia, and anaemia, viral, bacterial, fungal and/or parasitic infections, encephalopathy, gastrointestinal side effects like stomatitis, diarrhoea, bleeding from the G.I. tract or haemorrhage at any site, family history of partial or complete deficiency of the enzyme dihydropyrimidine dehydrogenase (DPD), had recent major surgery.

INTAXEL 260MG INJECTION contains Paclitaxel which belongs to a group of anti-cancer medicines called Taxanes. INTAXEL 260MG INJECTION is used to manage ovarian and breast cancer as a first line of therapy and as a second line of management when platinum containing medicines (such as cisplatin) or anthracyclines are insufficient to manage the disease in affected individuals. INTAXEL 260MG INJECTION is also used to manage advanced NSCLC (non-small cell lung cancer) when surgery/radiation therapy is not suitable. The medicine is also indicated for use to manage AIDS-related Kaposi’s sarcoma when other managements (such as anthracyclines) are insufficient to manage the disease in affected individuals. INTAXEL 260MG INJECTION is not recommended for use in patients allergic to paclitaxel and polyoxyethylated castor oil. It is also not recommended for use in patients with few white blood cells count and serious & uncontrolled infection. The medicine is also not used in patients suffering from severe liver disease. Before receiving INTAXEL 260MG INJECTION, inform your doctor if you had previously received radiation to your chest and/or suffering from thrombocytopenia (low platelet count)/acute infections (such as herpes zoster, chickenpox, herpes), kidney problems (such as chronic kidney disease), liver problems (such as mild/moderate hepatic impairment) and/or heart problems (such as severe coronary artery disease, myocardial infarction and arrhythmias).

INTRODUCTION ABOUT TAXONAB 100MG INJECTION TAXONAB 100MG INJECTION contains Paclitaxel which belongs to a group of anti-cancer medicines called Taxanes. TAXONAB 100MG INJECTION is used to manage ovarian and breast cancer as a first line of therapy and as a second line of management when platinum containing medicines (such as cisplatin) or anthracyclines are insufficient to manage the disease in affected individuals. TAXONAB 100MG INJECTION is also used to manage advanced NSCLC (non-small cell lung cancer) when surgery/radiation therapy is not suitable. The medicine is also indicated for use to manage AIDS-related Kaposi’s sarcoma when other managements (such as anthracyclines) are insufficient to manage the disease in affected individuals. TAXONAB 100MG INJECTION is not recommended for use in patients allergic to paclitaxel and polyoxyethylated castor oil. It is also not recommended for use in patients with few white blood cells count and serious & uncontrolled infection. The medicine is also not used in patients suffering from severe liver disease. Before receiving TAXONAB 100MG INJECTION, inform your doctor if you had previously received radiation to your chest and/or suffering from thrombocytopenia (low platelet count)/acute infections (such as herpes zoster, chickenpox, herpes), kidney problems (such as chronic kidney disease), liver problems (such as mild/moderate hepatic impairment) and/or heart problems (such as severe coronary artery disease, myocardial infarction and arrhythmias). TAXONAB 100MG INJECTION is not recommended for use during pregnancy. Women of child-bearing potential should use effective contraception method while receiving TAXONAB 100MG INJECTION which should be continued for next-6 months after completing the management. The medicine is also not recommended for use in breastfeeding women. TAXONAB 100MG INJECTION is also not recommended for use in children and adolescents (aged below 18 years). The medicine can be used with caution in elderly patients (aged above 65 years) after consulting the doctor. The most common side effects of receiving TAXONAB 100MG INJECTION are minor allergic reactions (such as flushing, rash, itching), shortness of breath, sore throat/mouth ulcers, diarrhea, nausea, vomiting and/or loss of hair. Consult your doctor if any of these symptoms worsen. USES OF TAXONAB 100MG INJECTION Manage ovarian and breast cancer. Manage advanced NSCLC (non-small cell lung cancer) Manage AIDS-related Kaposi’s sarcoma in affected individuals. HOW TAXONAB 100MG INJECTION WORKS TAXONAB 100MG INJECTION works by interfering with the microtubule structures in the cell (substance which aids cancer cells to divide and multiply) thus inhibiting the growth of cancer cells and managing its spread in affected individuals. DIRECTIONS FOR USE TAXONAB 100MG INJECTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition. SIDE EFFECTS OF TAXONAB 100MG INJECTION COMMON minor allergic reactions such as flushing, rash and/or itching infections such as upper respiratory infection, urinary tract infection shortness of breath sore throat/mouth ulcers, sore and red mouth diarrhea, nausea, vomiting loss of hair pain in the muscles, cramps, joints fever, severe chills, headache, dizziness, tiredness, looking pale bleeding, bruising more easily than normal signs of peripheral neuropathy such as numbness, tingling/weakness in arms and legs temporary mild nail change and skin changes reactions at injection sites such as localized swelling, pain and/or redness of the skin. UNCOMMON septic shock (severe drop in blood pressure) due to infections racing heartbeat, rapid beating of the heart, respiratory distress, heart attack, heart block fatigue, sweating, fainting, significant allergic reactions, phlebitis (inflammation of a vein), swelling of the face, lips, mouth, tongue and/or throat back pain, chest pain, pain around hands and feet, chills, abdominal pain. RARE febrile neutropenia (type of fever) due to low white blood cell count associated with fever and increased risk of infection motor neuropathy (disease that affects your body’s motor nerves) pulmonary embolism (blockade of lung artery), lung fibrosis (damaged/scarred lung tissue), interstitial pneumonia (scarring of lung tissue), pleural effusion (build of fluid between lungs and chest) bowel obstruction, bowel perforation, inflammation of colon, inflammation of the pancreas (pancreatitis) skin redness peritonitis (inflammation of abdominal layer) fever, dehydration, weakness anaphylactic reactions (life threatening allergic reaction). HOW TO MANAGE SIDE EFFECTS Diarrhea: Drink plenty of water and stay hydrated. Try to avoid taking any medicine on your own to manage diarrhea. Consult your doctor and inform them if the symptom gets worse.

PYOclean® Spray is an innovative and patented purifying care to help manage localized cutaneous microbiota imbalances (superficial pyoderma and Malassezia dermatitis): pimples, scabs, etc. From the first signs of relapses. Thanks to its ingredients of 100% natural origin, PYOclean® Spray is a unique emulsion that also helps promote the skin’s natural defenses thanks to a prebiotic. PYOclean® Spray moisturizes, and helps reinforce the skin barrier. Thanks to its original patented texture, PYOclean® Spray perfectly adheres to the area, without massage, for a lasting action.

Ichmune C contains Cyclosporine an immunosuppressant that blocks the production of pro-inflammtory cytokines and is approved for use by USFDA for the long terms management of canine atopic dermatitits and for use in cats with atopic syndrome. Ichmune C offers a gradual dose tapering protocol that helps veterinarians to tailor dose as per the requirements of patients.

Fiprofort spray contains Fipronil and is indicated in the management of heavy flea & tick infestation. Fiprofort spray is safe on pet’s hair and coat and stays for long duration for lasting protection.

Fiprofort Plus is a combination of the adulticide Fipronil and the insect growth regulator S-methoprene. Fipronil paralyses & kills adult fleas /ticks, while S-methoprene aids to break the life cycle of fleas, thereby helping in controlling the population of fleas in the environment. It offers one-month protection from fleas and ticks. Fiprofort Plus is safe for pets & pet parents. It breaks flea lifecycles & prevents re-infestation. Clinical studies have shown that Fiprofort Plus reduces the egg laying and hatching capacity in female ticks. Monthly use of Fiprofort Plusalong with integrated pest management measures can reduce flea and tick burden.

Ataxin contains Enrofloaxacin, a broad spectrum antibiotic indicated for the management of diseases associated with bacteria susceptible to enrofloxacin like deep pyodermas, recurrent infections of the urogenital tract, infectious otitis, lower respiratory tract infections. It may also be used in either dogs or cats to combat infections involving Pseudomonas. Enrofloxacin is also active against Staphylococci and thus is commonly used for skin infections.